Clinical Trial Update: Clinical Trial of YH14618 in Patients With Degenerative Disc Disease [Phase 2]

View source ↗

Summary

The Phase 2 trial of YH14618 for degenerative disc disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• YH14618

Snippet

Sponsor: Yuhan Corporation | Conditions: Disc Degenerative Disease | Phase 2 | Status: COMPLETED